Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy

Yo ichi Yamashita, Ken Shirabe, Takeo Toshima, Eiji Tsuijita, Kazuki Takeishi, Norifumi Harimoto, Toru Ikegami, Tomoharu Yoshizumi, Tetsuo Ikeda, Yuji Soejima, Yoshihiko Maehara

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aim: Hepatitis C (HC)-related hepatocellular carcinoma (HCC; HC-HCC) is highly recurrent. Methods: From 1995-2007, 183 curative hepatic resections for primary solitary HC-HCC without postoperative interferon therapy were included in this study. The patients were divided into three groups: (i) 2cm or less (n=56); (ii) more than 2cm to less than 5cm (n=79); and (iii) 5cm or more (n=48). Independent risk factors for HC-HCC recurrence for each group were determined. Results: Independent risk factors for recurrence were aspartate aminotransferase or alanine aminotransferase (AST/ALT) of 80IU/L or more (hazard ratio [HR], 2.1; P=0.02) in patients with HCC of 2cm or less, des-γ-carboxy prothrombin of 100mAU/mL or more (HR, 2.5; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of more than 2cm to less than 5cm, and the presence of macroscopic portal vein tumor thrombus (HR, 2.8; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of 5cm or more. All 13 late recurrences of 1 year or more after hepatic resection (27.1%) in patients with HCC of 5cm or more were accompanied by AST/ALT of 80IU/L or more. Conclusion: AST/ALT of 80IU/L or more is an independent risk factor for the recurrence of primary solitary HC-HCC after curative resection irrespective of the primary HC-HCC size.

Original languageEnglish
Pages (from-to)1313-1320
Number of pages8
JournalHepatology Research
Volume43
Issue number12
DOIs
Publication statusPublished - Dec 1 2013

Fingerprint

Hepatitis C
Interferons
Hepatocellular Carcinoma
Recurrence
Therapeutics
Liver
Prothrombin
Aspartate Aminotransferases
Portal Vein
Alanine Transaminase
Thrombosis
Neoplasms

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Infectious Diseases

Cite this

Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy. / Yamashita, Yo ichi; Shirabe, Ken; Toshima, Takeo; Tsuijita, Eiji; Takeishi, Kazuki; Harimoto, Norifumi; Ikegami, Toru; Yoshizumi, Tomoharu; Ikeda, Tetsuo; Soejima, Yuji; Maehara, Yoshihiko.

In: Hepatology Research, Vol. 43, No. 12, 01.12.2013, p. 1313-1320.

Research output: Contribution to journalArticle

Yamashita, Yo ichi ; Shirabe, Ken ; Toshima, Takeo ; Tsuijita, Eiji ; Takeishi, Kazuki ; Harimoto, Norifumi ; Ikegami, Toru ; Yoshizumi, Tomoharu ; Ikeda, Tetsuo ; Soejima, Yuji ; Maehara, Yoshihiko. / Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy. In: Hepatology Research. 2013 ; Vol. 43, No. 12. pp. 1313-1320.
@article{4075b48a23494ea4b597afa9372829de,
title = "Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy",
abstract = "Aim: Hepatitis C (HC)-related hepatocellular carcinoma (HCC; HC-HCC) is highly recurrent. Methods: From 1995-2007, 183 curative hepatic resections for primary solitary HC-HCC without postoperative interferon therapy were included in this study. The patients were divided into three groups: (i) 2cm or less (n=56); (ii) more than 2cm to less than 5cm (n=79); and (iii) 5cm or more (n=48). Independent risk factors for HC-HCC recurrence for each group were determined. Results: Independent risk factors for recurrence were aspartate aminotransferase or alanine aminotransferase (AST/ALT) of 80IU/L or more (hazard ratio [HR], 2.1; P=0.02) in patients with HCC of 2cm or less, des-γ-carboxy prothrombin of 100mAU/mL or more (HR, 2.5; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of more than 2cm to less than 5cm, and the presence of macroscopic portal vein tumor thrombus (HR, 2.8; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of 5cm or more. All 13 late recurrences of 1 year or more after hepatic resection (27.1{\%}) in patients with HCC of 5cm or more were accompanied by AST/ALT of 80IU/L or more. Conclusion: AST/ALT of 80IU/L or more is an independent risk factor for the recurrence of primary solitary HC-HCC after curative resection irrespective of the primary HC-HCC size.",
author = "Yamashita, {Yo ichi} and Ken Shirabe and Takeo Toshima and Eiji Tsuijita and Kazuki Takeishi and Norifumi Harimoto and Toru Ikegami and Tomoharu Yoshizumi and Tetsuo Ikeda and Yuji Soejima and Yoshihiko Maehara",
year = "2013",
month = "12",
day = "1",
doi = "10.1111/hepr.12091",
language = "English",
volume = "43",
pages = "1313--1320",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Risk factors for recurrence after curative resection of hepatitis C-related hepatocellular carcinoma in patients without postoperative interferon therapy

AU - Yamashita, Yo ichi

AU - Shirabe, Ken

AU - Toshima, Takeo

AU - Tsuijita, Eiji

AU - Takeishi, Kazuki

AU - Harimoto, Norifumi

AU - Ikegami, Toru

AU - Yoshizumi, Tomoharu

AU - Ikeda, Tetsuo

AU - Soejima, Yuji

AU - Maehara, Yoshihiko

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Aim: Hepatitis C (HC)-related hepatocellular carcinoma (HCC; HC-HCC) is highly recurrent. Methods: From 1995-2007, 183 curative hepatic resections for primary solitary HC-HCC without postoperative interferon therapy were included in this study. The patients were divided into three groups: (i) 2cm or less (n=56); (ii) more than 2cm to less than 5cm (n=79); and (iii) 5cm or more (n=48). Independent risk factors for HC-HCC recurrence for each group were determined. Results: Independent risk factors for recurrence were aspartate aminotransferase or alanine aminotransferase (AST/ALT) of 80IU/L or more (hazard ratio [HR], 2.1; P=0.02) in patients with HCC of 2cm or less, des-γ-carboxy prothrombin of 100mAU/mL or more (HR, 2.5; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of more than 2cm to less than 5cm, and the presence of macroscopic portal vein tumor thrombus (HR, 2.8; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of 5cm or more. All 13 late recurrences of 1 year or more after hepatic resection (27.1%) in patients with HCC of 5cm or more were accompanied by AST/ALT of 80IU/L or more. Conclusion: AST/ALT of 80IU/L or more is an independent risk factor for the recurrence of primary solitary HC-HCC after curative resection irrespective of the primary HC-HCC size.

AB - Aim: Hepatitis C (HC)-related hepatocellular carcinoma (HCC; HC-HCC) is highly recurrent. Methods: From 1995-2007, 183 curative hepatic resections for primary solitary HC-HCC without postoperative interferon therapy were included in this study. The patients were divided into three groups: (i) 2cm or less (n=56); (ii) more than 2cm to less than 5cm (n=79); and (iii) 5cm or more (n=48). Independent risk factors for HC-HCC recurrence for each group were determined. Results: Independent risk factors for recurrence were aspartate aminotransferase or alanine aminotransferase (AST/ALT) of 80IU/L or more (hazard ratio [HR], 2.1; P=0.02) in patients with HCC of 2cm or less, des-γ-carboxy prothrombin of 100mAU/mL or more (HR, 2.5; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of more than 2cm to less than 5cm, and the presence of macroscopic portal vein tumor thrombus (HR, 2.8; P=0.02) and AST/ALT of 80IU/L or more (HR, 2.1; P=0.04) in patients with HCC of 5cm or more. All 13 late recurrences of 1 year or more after hepatic resection (27.1%) in patients with HCC of 5cm or more were accompanied by AST/ALT of 80IU/L or more. Conclusion: AST/ALT of 80IU/L or more is an independent risk factor for the recurrence of primary solitary HC-HCC after curative resection irrespective of the primary HC-HCC size.

UR - http://www.scopus.com/inward/record.url?scp=84890907258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890907258&partnerID=8YFLogxK

U2 - 10.1111/hepr.12091

DO - 10.1111/hepr.12091

M3 - Article

AN - SCOPUS:84890907258

VL - 43

SP - 1313

EP - 1320

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 12

ER -